Demodex treatment advances, faux-stasis, and how to approach generics entering into the marketplace

https://is1-ssl.mzstatic.com/image/thumb/Podcasts114/v4/41/19/a4/4119a48c-a077-e56b-dc8b-f23d0c0f6bd9/mza_17537292924045097735.jpg/600x600bb.jpg

Ophthalmology Interventional Mindset

Interventional Mindset

25 episodes

5 days ago

Our educational series gives eye physicians the needed knowledge edge and confidence in mastering new technology to grow their practices and provide the highest patient care. We are the bridge of real world information to take you from where you are to where you want to be.

Medicine

Health & Fitness

RSS

All content for Ophthalmology Interventional Mindset is the property of Interventional Mindset and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Medicine

Health & Fitness

https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_nologo400/9813076/9813076-1602449247935-90d73d29bbef2.jpg

Demodex treatment advances, faux-stasis, and how to approach generics entering into the marketplace

Ophthalmology Interventional Mindset

42 minutes 2 seconds

3 years ago

Demodex treatment advances, faux-stasis, and how to approach generics entering into the marketplace

In this episode Dr Darrell White, Dr Gary Wortz, and Dr Preeya Gupta discuss TP03 for treating demodex and the emergence of demodex as a cofounder in ocular surface disease. And can't miss their take on generic cyclosporine entering the market, its impact on patients and clinicians in addition to learning how not all cyclosporine is the same.